Concord Healthcare Launches China’s First Proton Therapy AI Model Delivering Precise Cancer Treatment

Concord Healthcare Launches China’s First Large Language Model for Proton Therapy

Concord Healthcare Group (NYSE: CCM), a subsidiary of Concord Medical Services Holdings, has unveiled Rhea-AI, the first large language model (LLM) in China dedicated to proton therapy. The model is currently deployed at Guangzhou Concord Cancer Hospital, where it has already contributed to several successful patient treatments.

Rhea-AI is built on a foundation of nearly 10,000 high-quality radiotherapy cases, combining multimodal medical data, Proton China datasets, and extensive professional journal literature. This comprehensive integration supports precise treatment planning, delivering significant clinical benefits while minimizing side effects for patients.

Leading Technology in Proton Therapy

• First proton therapy-focused LLM developed in China.
• Successfully validated through multiple patient treatment cases at Guangzhou Concord Cancer Hospital.
• Model accuracy enhanced by integrating vast, high-quality radiotherapy datasets.
• Demonstrated clinical outcomes include precise targeting, improved efficacy, and reduced adverse effects.

Concord Healthcare leverages years of experience and a large repository of tumor diagnosis and treatment data to develop this specialized AI model. The company’s approach brings together clinical expertise and advanced data analysis to improve proton therapy’s effectiveness.

About Concord Medical and Concord Healthcare

Concord Medical Services Holdings Limited is a healthcare provider offering comprehensive oncology services, including cancer diagnosis, treatment, education, and prevention. Its network of self-owned cancer hospitals and clinics is equipped with advanced technology such as state-of-the-art proton therapy systems. The company focuses on improving both the quality and accessibility of cancer care across China.

Concord Healthcare operates as an oncology healthcare provider, serving patients through its own medical institutions while supplying medical equipment, software, and related services to third-party hospitals. Its integrated oncology services include sales, installation, management, technical support, and operating leases, supporting precision radiation therapy and multidisciplinary treatment approaches.

For more information on advanced AI applications in healthcare, explore resources on Complete AI Training.